Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
MK-4646 Single Ascending Dose Study and DDI in Healthy Participants
Merck Sharp and Dohme
HIV infection
1 trial -
MK-7091 Formulations Study in Healthy Adult Participants
Merck Sharp and Dohme
Hypercholesterolemia
1 trial -
MK-7480 Multiple Ascending Dose Study in Healthy Participants
Merck Sharp and Dohme
Non-alcoholic steatohepatitis
1 trial -
MLN1202
Takeda
Healthy Japanese and Caucasian Male Adults
1 trial -
MLN3126
Takeda
Healthy Volunteers
1 trial -
MOR106
Lakefront Biotherapeutics NV
Healthy
1 trial -
MOR106 single ascending doses, intravenous
Lakefront Biotherapeutics NV
Healthy
1 trial -
MRT-6160
Monte Rosa Therapeutics
Healthy Volunteers
1 trial -
MRT-8102
Monte Rosa Therapeutics
Healthy Volunteers
1 trial -
MS200569_0065
Merck Sharp and Dohme
Healthy
1 trial -
MSB11455
Fresenius Kabi Australia Pty Limited
Healthy
1 trial -
MSB11456
Fresenius Kabi Australia Pty Limited
Healthy
1 trial -
MT-1186
Tanabe Pharma
Healthy Adult Subjects
1 trial -
MT203 80 mg or matching Placebo
Takeda
Healthy Volunteers
1 trial -
MZE001
Maze Therapeutics
Healthy
1 trial -
Maribavir
Takeda
Healthy Volunteers
2 trials -
Maribavir (400 mg)
Takeda
Healthy Volunteers
1 trial -
Maribavir Commercial Tablet Formulation
Takeda
Healthy Volunteers
1 trial -
Mass Balance Study of [14C] ABBV-932 in Healthy Male Volunteers
AbbVie Deutschland GmbH & Co. KG
Healthy Volunteers
1 trial -
Mavorixafor
X4 Pharmaceuticals, Inc
Healthy Participants
1 trial -
Meloxicam 15 mg Tablets
Teva Pharma GmbH
Healthy
2 trials -
Mepolizumab
BRIGHT MINDS BIOSCIENCES INC.
Healthy Subjects
1 trial -
Mesalamine
Takeda
Healthy
1 trial -
Methosulide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.